First Allied Advisory Services, Inc. - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 88 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2016. The put-call ratio across all filers is 1.30 and the average weighting 0.0%.

Quarter-by-quarter ownership
First Allied Advisory Services, Inc. ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2020$3,463,000
+50.1%
80,1750.0%0.13%
+29.3%
Q1 2020$2,307,000
-39.7%
80,175
+32.8%
0.10%
-23.3%
Q4 2019$3,828,000
+125.0%
60,352
+0.0%
0.13%
+111.5%
Q3 2019$1,701,000
+6.4%
60,3500.0%0.06%
+10.9%
Q2 2019$1,599,000
+23.8%
60,350
-14.2%
0.06%
+25.0%
Q1 2019$1,292,000
+48.0%
70,3500.0%0.04%
+29.4%
Q4 2018$873,000
-24.5%
70,350
+16.6%
0.03%
-15.0%
Q3 2018$1,157,000
+32.2%
60,350
-6.2%
0.04%
+21.2%
Q2 2018$875,000
+98.9%
64,350
+5.5%
0.03%
+94.1%
Q1 2018$440,000
+95.6%
61,0000.0%0.02%
+88.9%
Q4 2017$225,000
-14.8%
61,0000.0%0.01%
-18.2%
Q3 2017$264,000
+166.7%
61,0000.0%0.01%
+175.0%
Q2 2017$99,000
-10.8%
61,000
+1.7%
0.00%
-33.3%
Q1 2017$111,000
+16.8%
60,000
-1.6%
0.01%
+20.0%
Q4 2016$95,000
-78.8%
61,0000.0%0.01%
-79.2%
Q3 2016$448,000
+38.3%
61,0000.0%0.02%
+33.3%
Q2 2016$324,00061,0000.02%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q2 2016
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 908,474$24,410,69622.12%
Western Financial Corp/CA 820,239$22,039,82216.16%
JOHNSON & JOHNSON 247,598$6,652,9582.45%
WEALTH EFFECTS LLC 164,750$4,426,8352.19%
M28 Capital Management LP 67,400$1,811,0382.08%
Privium Fund Management B.V. 259,036$6,960,2982.07%
Evolutionary Tree Capital Management, LLC 51,266$1,377,5171.78%
Avidity Partners Management LP 1,063,897$28,586,9121.15%
SECTORAL ASSET MANAGEMENT INC 157,552$4,233,4220.82%
Vivo Capital, LLC 137,411$3,692,2340.40%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders